Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Real-world data at ARVO highlight transformational outcomes seen with Lucentis®, including lower injection frequency than in original clinical trials

21:30 EDT 7 May 2013 | Thomson Reuters
This article has expired, however you can still download the PDF.
Preview:
Novartis International AG / Real-world data at ARVO highlight transformational outcomes seen with Lucentis®, including lower injection frequency than in original clinical trials . Processed and transmitted by Thomson Reuters ONE. The issuer is solely re...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Real-world data at ARVO highlight transformational outcomes seen with Lucentis®, including lower injection frequency than in original clinical trials"

Search BioPortfolio: